Skip to main content

Risk stratification for lateral involvement in papillary thyroid carcinoma patients with central lymph node metastasis

Endocrine volume 68, pages 320–328 (2020)Cite this article

Abstract

Purpose

To effectively predict lateral neck lymph nodes (LLN) metastasis in papillary thyroid carcinoma (PTC) patients with central lymph nodes (CLN) invasion, and devise targeted treatment strategies.

Methods

Four hundred and thirty-four PTC patients with CLN metastasis from two medical centers were retrospectively analyzed. A new statistical model was established for predicting LLN involvement in these patients to guide lymph nodes management strategies.

Results

Patients with more than five positive CLN metastasis appeared to have extremely high risk (83.0%) of LLN involvement. For patients with five or less positive CLN invasion, multivariate logistic analyses were applied. Independent risk factors for LLN involvement were determined to be: age over 40, maximum tumor diameter of no less than 1.0 cm, existence of thyroid capsular invasion, and tumor with ipsilateral nodular goiter (iNG). These factors were used to construct a predictive nomogram. The accuracy and validity of our newly built model were verified by C-index 0.761 (95% CI, 0.707–0.815) in development cohort and 0.759 (95% CI, 0.745–0.773) in validation cohort and calibration curve. The patients were stratified into three groups based on their nomogram risk scores. Possible LLN involvement rates for low-risk, moderate-risk, and relatively high-risk subgroups were 8.9%, 22.8%, and 48.2%, respectively.

Conclusions

Our newly established model can effectively predict possible LLN metastasis in PTC patients, and a new strategy selection flow chart was created for patients with positive CLN invasion. For patients in high-risk group, prophylactic LLN dissection is recommended, if not, adjuvant radioactive iodine or a closer follow-up scheme should at least be conducted. For those in low-risk group, surgical intervention is unnecessary and regular follow-up is recommended.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. M.A. Rosenbaum, C.R. McHenry, Contemporary management of papillary carcinoma of the thyroid gland. Expert Rev. Anticancer Ther. 9(3), 317–329 (2009)

    CAS  Article  Google Scholar 

  2. S.A. Hundahl, I.D. Fleming, A.M. Fremgen, H.R. Menck, A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995 [see comments]. Cancer 83(12), 2638–2648 (1998)

    CAS  Article  Google Scholar 

  3. Y.D. Podnos, D. Smith, L.D. Wagman, J.D. Ellenhorn, The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am. Surg. 71(9), 731–734 (2005)

    PubMed  Google Scholar 

  4. J.W. Feng, X. H. Yang, B. Q. Wu, D. L. Sun, Y. Jiang, Z. Qu. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma. Clin. Transl. Oncol. (2019).

  5. G. Mercante, A. Frasoldati, C. Pedroni, D. Formisano, L. Renna, S. Piana, G. Gardini et al. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients. Thyroid 19(7), 707–716 (2009)

    CAS  Article  Google Scholar 

  6. H. Takami, Y. Ito, T. Okamoto, A. Yoshida, Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons. World J. Surg. 35(1), 111–121 (2011)

    Article  Google Scholar 

  7. X. Wu, B. Li, C. Zheng, X. He, Risk factors for central lymph node metastases in patients with papillary thyroid microcarcinoma. Endocr. Pract. 24(12), 1057–1062 (2018)

    Article  Google Scholar 

  8. A. Machens, S. Hauptmann, H. Dralle, Lymph node dissection in the lateral neck for completion in central node-positive papillary thyroid cancer. Surgery 145(2), 176–181 (2009)

    Article  Google Scholar 

  9. X. Lan, W. Sun, H. Zhang, W. Dong, Z. Wang, T. Zhang, A meta-analysis of central lymph node metastasis for predicting lateral involvement in papillary thyroid carcinoma. Otolaryngol. Head. Neck Surg. 153(5), 731–738 (2015)

    Article  Google Scholar 

  10. M.J. Jeon, M.S. Chung, H. Kwon, M. Kim, S. Park, J.H. Baek et al. Features of papillary thyroid microcarcinoma associated with lateral cervical lymph node metastasis. Clin. Endocrinol. 86(6), 845–851 (2017)

    Article  Google Scholar 

  11. R.C. Zeng, W. Zhang, E.L. Gao, P. Cheng, G.L. Huang, X.H. Zhang et al. Number of central lymph node metastasis for predicting lateral lymph node metastasis in papillary thyroid microcarcinoma. Head Neck 36(1), 101–106 (2014)

    Article  Google Scholar 

  12. Y. Tao, C. Wang, L. Li, H. Xing, Y. Bai, B. Han et al. Clinicopathological features for predicting central and lateral lymph node metastasis in papillary thyroid microcarcinoma: analysis of 66 cases that underwent central and lateral lymph node dissection. Mol. Clin. Oncol. 6(1), 49–55 (2017)

    Article  Google Scholar 

  13. K.A. Pathak, A. Mazurat, P. Lambert, T. Klonisch, R.W. Nason, Prognostic nomograms to predict oncological outcome of thyroid cancers. J. Clin. Endocrinol. Metab. 98(12), 4768–4775 (2013)

    CAS  Article  Google Scholar 

  14. J.D. Isaacs, T.P. McMullen, S.B. Sidhu, M.S. Sywak, B.G. Robinson, L.W. Delbridge et al. Predictive value of the Delphian and level VI nodes in papillary thyroid cancer. ANZ J. Surg. 80(11), 834–838 (2010)

    Article  Google Scholar 

  15. A.R. Shaha, Prognostic factors in papillary thyroid carcinoma and implications of large nodal metastasis. Surgery 135(2), 237–239 (2004)

    Article  Google Scholar 

  16. K.E. Lee, I.Y. Chung, E. Kang, H. Koo do, K.H. Kim, S.W. Kim et al. Ipsilateral and contralateral central lymph node metastasis in papillary thyroid cancer: patterns and predictive factors of nodal metastasis. Head. Neck. 35(5), 672–676 (2013)

    Article  Google Scholar 

  17. I.D. Hay, C.S. Grant, J.A. van Heerden, J.R. Goellner, J.R. Ebersold, E.J. Bergstralh, Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 112(6), 1139–1147 (1992)

    CAS  PubMed  Google Scholar 

  18. N.J. Beasley, J. Lee, S. Eski, P. Walfish, I. Witterick, J.L. Freeman et al. Impact of nodal metastases on prognosis in patients with well-differentiated thyroid cancer. Arch. Otolaryngol. Head. Neck Surg. 128(7), 825–828 (2002)

    Article  Google Scholar 

  19. A. Goropoulos, K. Karamoshos, A. Christodoulou, T. Ntitsias, K. Paulou, A. Samaras et al. Value of the cervical compartments in the surgical treatment of papillary thyroid carcinoma. World J. Surg. 28(12), 1275–1281 (2004)

    Article  Google Scholar 

  20. J.E. Ahn, J.H. Lee, J.S. Yi, Y.K. Shong, S.J. Hong, D.H. Lee et al. Diagnostic accuracy of CT and ultrasonography for evaluating metastatic cervical lymph nodes in patients with thyroid cancer. World J. Surg. 32(7), 1552–1558 (2008)

    Article  Google Scholar 

  21. H.S. Hwang, L.A. Orloff, Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer. Laryngoscope 121(3), 487–491 (2011)

    Article  Google Scholar 

  22. Y. Ito, T. Higashiyama, Y. Takamura, A. Miya, K. Kobayashi, F. Matsuzuka et al. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J. Surg. 31(11), 2085–2091 (2007)

    Article  Google Scholar 

  23. L. Zhang, W.J. Wei, Q.H. Ji, Y.X. Zhu, Z.Y. Wang, Y. Wang et al. Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients. J. Clin. Endocrinol. Metab. 97(4), 1250–1257 (2012)

    CAS  Article  Google Scholar 

  24. Y. Qiu, Y. Fei, J. Liu, C. Liu, X. He, N. Zhu et al. Prevalence, risk factors and location of skip metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis. Cancer Manag. Res. 11, 8721–8730 (2019)

    Article  Google Scholar 

  25. G.W. Randolph, Q.Y. Duh, K.S. Heller, V.A. LiVolsi, S.J. Mandel, D.L. Steward et al. The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension. Thyroid 22(11), 1144–1152 (2012)

    Article  Google Scholar 

  26. H. Bohec, I. Breuskin, J. Hadoux, M. Schlumberger, S. Leboulleux, D.M. Hartl et al. Occult contralateral lateral lymph node metastases in unilateral N1b papillary thyroid carcinoma. World J. Surg. 43(3), 818–823 (2019)

    Article  Google Scholar 

  27. S.K. Kim, J.W. Woo, J.H. Lee, I. Park, J.H. Choe, J.H. Kim, Role of BRAF V600E mutation as an indicator of the extent of thyroidectomy and lymph node dissection in conventional papillary thyroid carcinoma. Surgery 158(6), 1500–1511 (2015)

    Article  Google Scholar 

  28. A.M. Thompson, R.M. Turner, A. Hayen, A. Aniss, S. Jalaty, D.L. Learoyd, A. Preoperative, Nomogram for the prediction of ipsilateral central compartment lymph node metastases in papillary thyroid cancer. Thyroid 24(4), 675–682 (2014)

    CAS  Article  Google Scholar 

  29. S.K. Kim, Y.J. Chai, I. Park, J.W. Woo, J.H. Lee, K.E. Lee, Nomogram for predicting central node metastasis in papillary thyroid carcinoma. J. Surgical Oncol. 115(3), 266–272 (2016)

    Article  Google Scholar 

  30. J.L. Roh, J.M. Kim, C.I. Park, Central lymph node metastasis of unilateral papillary thyroid carcinoma: patterns and factors predictive of nodal metastasis, morbidity, and recurrence. Ann. Surgical Oncol. 18(8), 2245–2250 (2011)

    Article  Google Scholar 

  31. V.P. Balachandran, M. Gonen, J.J. Smith, R.P. DeMatteo, Nomograms in oncology: more than meets the eye. Lancet Oncol. 16(4), e173–e180 (2015)

    Article  Google Scholar 

Download references

Acknowledgements

This study was supported by the Science and Technology Innovation Project of Shanghai Shenkang Hospital Clinical Development Center under Grand [SHDC12015114]; the Science and Technology Commission of Shanghai Municipality under Grand [16411950100]; the National Natural Science Foundation of China under Grand [81772878, 30801283, 30972691]; the Shanghai Science and Technology Development Funds under Grand [09QA1401000, 10QA1405900, 14411961900]; the Training Program of the Excellent Young Talents of Shanghai Municipal Health System under Grand [XYQ2011055, XYQ2011015]; and the Shanghai Municipal Science and Technology Foundation under Grand [11JC1410802].

Author contributions

All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by Y.H., Z.Y., L.T., and W.C. The first draft of the paper was written by Y.H. and Z.Y., and all authors commented on previous versions of the paper. All authors read and approved the final paper.

Author information

Author notes

  1. These authors contributed equally: Yu Heng, Zheyu Yang

  2. These authors contributed equally: Lei Tao, Wei Cai

Affiliations

  1. Department of Otolaryngology, Eye Ear Nose and Throat Hospital, Fudan University, 83 Fenyang Road, Shanghai, 200031, China

    Yu Heng, Liang Zhou & Lei Tao

  2. Department of General Surgery, School of medicine affiliated Ruijin Hospital, Shanghai Jiaotong University, 197 Ruijin 2nd Road, Shanghai, 200031, China

    Zheyu Yang, Jianwei Lin & Wei Cai

Authors
  1. Yu Heng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zheyu Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Liang Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jianwei Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wei Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lei Tao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Wei Cai or Lei Tao.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Ethics Committee of the Eye and ENT Hospital of Fudan University and the Ruijin Hospital of Shanghai Jiao Tong University School of Medicine, and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Heng, Y., Yang, Z., Zhou, L. et al. Risk stratification for lateral involvement in papillary thyroid carcinoma patients with central lymph node metastasis. Endocrine 68, 320–328 (2020). https://doi.org/10.1007/s12020-020-02194-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-020-02194-8

Keywords

  • Papillary thyroid carcinoma
  • Lateral lymph node metastasis
  • Predictive model
  • Treatment strategy
  • Risk stratification